Diabetes medication classes
Pro Research Analysisby 
Searched over 200M research papers
Overview of Diabetes Medication Classes
There are currently 12 main classes of medications approved for the treatment of diabetes, including both oral and injectable options, with insulin being a key injectable therapy. Each class contains several agents that differ in dosing, administration, side effects, and drug interactions, allowing for tailored treatment based on individual patient needs Stahnke2020Tran2015.
Oral Diabetes Medication Classes
Biguanides (Metformin)
Metformin, a biguanide, is the most commonly prescribed first-line oral medication for type 2 diabetes due to its effectiveness, safety profile, and high rates of patient adherence and persistence Raval2020Dahlén2022Tran2015+2 MORE.
Sulfonylureas
Sulfonylureas are another long-standing class, but their use has declined in recent years due to the risk of hypoglycemia and the availability of newer agents Raval2020Dahlén2022Tran2015+1 MORE.
Thiazolidinediones (TZDs)
Thiazolidinediones, such as pioglitazone, have also seen reduced use, mainly due to concerns about side effects and safety Raval2020Dahlén2022Tran2015+1 MORE.
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
DPP-4 inhibitors are newer oral agents that have gained popularity because of their favorable side effect profile and ease of use Raval2020Dahlén2022Tran2015+3 MORE.
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors
SGLT2 inhibitors are another newer class that has seen rapid growth in use, especially due to their benefits for heart and kidney health, as well as patient preference for their regimen and side effect profile Raval2020Dahlén2022Tran2015+4 MORE.
Meglitinides and Alpha-Glucosidase Inhibitors
Other oral classes include meglitinides and alpha-glucosidase inhibitors, though these are less commonly used due to limited efficacy or tolerability Dahlén2022Tran2015.
Injectable Diabetes Medication Classes
Insulin
Insulin remains essential for many patients, especially those with type 1 diabetes or advanced type 2 diabetes. There are various types of insulin, including rapid-acting, long-acting, and premixed formulations Stahnke2020Dahlén2022Tran2015+1 MORE.
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
GLP-1 receptor agonists are non-insulin injectables that have become increasingly popular due to their glucose-lowering effects, weight loss benefits, and low risk of hypoglycemia Raval2020Dahlén2022Tran2015+2 MORE.
Combination Therapies
Many patients require more than one medication to achieve optimal blood sugar control. Combination therapies, often including metformin with another class such as SGLT2 inhibitors or DPP-4 inhibitors, are common and can improve outcomes Stahnke2020Dahlén2022Tran2015+1 MORE.
Trends and Patient Preferences
Recent years have seen a shift toward newer medication classes, particularly SGLT2 inhibitors and GLP-1 receptor agonists, which are preferred by patients for their convenience and lower risk of side effects Raval2020Dahlén2022Maruthur2016+2 MORE. Metformin remains the most adhered-to medication, while injectable therapies like insulin and GLP-1 agonists have lower adherence rates, often due to side effects or complexity of use .
Conclusion
Diabetes management now includes a wide range of medication classes, each with unique benefits and considerations. Metformin, SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists are among the most commonly used and preferred options, while older classes like sulfonylureas and TZDs are used less frequently. The choice of therapy should be individualized, considering efficacy, safety, patient preferences, and comorbidities Stahnke2020Raval2020Dahlén2022+5 MORE.
Sources and full results
Most relevant research papers on this topic